2
SYNOVA’s growth continues with new subsidiary in Germany
plus
Actualités sur Enterprises
- Langue:
- Médias:
- Période:
- Période:Totale
Consulting firms AWK Group and Ginkgo Management Consulting grow to 800 advisors and strengthen footprint in Europe and Asia through merger with Quint Group
plusDEBIOPHARM AND UBIX THERAPEUTICS LAUNCH RESEARCH TO DEVELOP A NEW ANTI-CANCER MODALITY - ANTIBODY DEGRADUCER® CONJUGATES
Lausanne, Switzerland, Seoul, Republic of Korea (ots) - Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company and Ubix Therapeutics (en.ubixtrx.com), a South Korea-based biotech company today announced their co-research agreement combining two novel proprietary technologies to specifically ...
plusMEM industries: new orders above pre-crisis level
Zurich (ots) - Figures for the first quarter of 2021 released by the Swiss mechanical and electrical engineering industries (MEM industries) show a significant easing: new orders rose by +4.8% compared to the same period last year. Exports were also up, increasing by +3.3%. The key indicators suggest that most of the past year's pandemic-related declines will have been made up by the end of 2021. Margins in the MEM sector ...
plusSYNOVA has filed an appeal against Avonisys with the Swiss Federal Supreme Court
plusHostpoint speeds up access to websites around the globe with DNS Anycast
plus
Avonisys AG wins patent litigation case against Synova SA
plusGrünenthal is Recognized for its Strong Management of Environmental, Social and Governance (ESG) Risks
Aachen, Germany (ots) - - Leading global ESG ratings agency Sustainalytics notes Grünenthal is in the top five percent among its peers in the pharmaceutical subindustry - Grünenthal is categorized as “medium risk”, placing it ahead of its key subindustry peers and in the same league as multinational companies ...
plus- 2
Tiffany’s star jewelry designer and philanthropist Elsa Peretti dies in Spain
plus DEBIOPHARM AND GENOME & COMPANY JOIN FORCES TO CREATE NEW HIGHLY SPECIFIC THERAPIES FOR CANCER PATIENTS
Lausanne, Switzerland and Seongnam-si Gyeonggi-do, Republic of Korea (ots) - Korean and Swiss based companies leverage their oncology expertise to initiate a research collaboration to formulate novel antibody-drug conjugate (ADC) candidates Genome & Company (314130, CEO: Jisoo Pae, Hansoo Park), a global leading ...
plusMartin Bosshardt Appointed New Anapaya CEO / Bosshardt's 20 years of networking and security experience is expected to lead the company into 2021
plusNUCLEAI AND DEBIOPHARM LAUNCH RESEARCH COLLABORATION UTILIZING NUCLEAI’S AI-POWERED BIOMARKER PLATFORM
Tel Aviv, Israel / Lausanne, Switzerland (ots) - Nucleai (www.Nucleaimd.com), a global provider in pathology-based biomarker discovery, and Debiopharm (www.debiopharm.com), a Swiss-based biopharmaceutical company specializing in drug development, announced that they have entered into a long-term collaboration to ...
plus
Hostpoint now offers protection against domain loss
plus- 3
Max Lehner AG (MAXOLEN) Switzerland and DEGAMA Srl (AUTOEQUIP LAVAGGI) Italia agree an exclusive partnership for the distribution and provision of washing systems in Switzerland.
plus - 2
Global Retailer group OYSHO and Swiss apparel technology group X-BIONIC & X-SOCKS design a collection together / OYSHO by X-BIONIC I Once again, Fashion follows function
plus New model of corporate governance at Ricola
Laufen (ots) - Ricola separates the strategic and operational management of the company. As of January 2021, the members of the family owning the company will focus on their tasks in the Boards of Directors of Ricola Group Ltd. and the parent company Ricola Family Holding Ltd., leaving the operational management of the company to leaders from outside the family headed by CEO Thomas P. Meier. Eva Richterich, currently Head ...
plusRoche teams up with Diabeloop to advance the management of insulin pump therapy
Basel (ots) - - The partnership will create new opportunities to lower the burden for people with diabetes in daily therapy management and to improve therapy outcomes(1). - By partnering with Diabeloop, Roche steps into the field of automated insulin delivery (AID) representing a milestone in Roche's strategy of integrated Personalised Diabetes Management (iPDM). Roche ...
plusLodbrok Capital issues letter to Aryzta Board on AGM and decision on offer from Elliott Advisors (UK)
LONDON (ots) - Lodbrok Capital has today issued a letter to the Board of Aryzta in relation to binding offer from Elliott Advisors (UK) Limited ("Elliott") for the entire share capital of Aryzta at a price of 0.80 CHF per share. The letter makes clear our position that it would be highly inappropriate and grossly ...
plus
EMD - European Marketing Distribution
EMD: Eric Lemercier appointed director Business Development
plusswissstaffing - Verband der Personaldienstleister der Schweiz
Swiss Staffingindex - A Second Wave of Coronavirus Threatens the Swiss Labor Market
Un documentplusHostpoint now supports DNSSEC and DANE
plusFashion brand TOM TAILOR lays foundations for further enhancing its successful positioning in the casual lifestyle segment
Hamburg (ots) - - Tom Tailor GmbH (TOM TAILOR) retains its long-term strategic investor with extensive industry experience following its complete takeover by Fosun International Limited - Based on the milestones it has already achieved, TOM TAILOR will implement its development plan by taking specific strategic and ...
plusDEBIOPHARM HONORED AS A 2020 SWISS BIOTECH SUCCESS STORY WINNER FOR OUTSTANDING ACHIEVEMENTS OVER 40 YEARS
Lausanne, Switzerland (ots) - Debiopharm, (www.debiopharm.com), a Swiss-based biopharmaceutical company today announced being one of the recipients of the 2020 Swiss Biotech Success Story Award for exceptional achievements in the biotech industry. Every year, the Swiss Biotech Association awards companies or ...
plusDEBIOPHARM TO PRESENT LATE BREAKING HEAD & NECK CANCER ABSTRACT AT THE 2020 EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS
Lausanne, Switzerland (ots) - Debiopharm announces the presentation of the 3-year phase II follow-up data along with 2 posters for xevinapant (antagonist of IAP -Inhibitor of Apoptosis Proteins) and WEE1 inhibitor Debio 0123 Debiopharm, ...
Un documentplus
Synova substantially limits the Swiss part of EP 1833636 B1 as granted before the Swiss Federal Institute of Intellectual Property
Zug (ots) - Following substantial evidence brought up against the validity of Synova's EP 1833636 B1 by Avonisys AG in ongoing court proceedings before the Swiss Federal Patent Court, Synova substantially limited the original patent on 14 August 2020 by means of limitation proceedings before the Swiss Federal ...
plusMSD (Merck Sharp & Dohme AG) Switzerland appoints Ans Heirman, Ph.D. as the new Managing Director of MSD Switzerland, effective September 1st, 2020
Un documentplusNet profit increases 28% to CHF 537 million in the first half of 2020
Zurich (ots) - - Outstanding result for first half of 2020 underscores bank's solid business model - Increased operating income of CHF 1,310 million (+12.4%), with positive results across all income drivers - Significantly lower cost/income ratio of 55.2% - Excellent net inflow of new money totalling CHF ...
Un documentplusThe Future of Real Estate: Sustainable Construction Innovation
Stuttgart (ots) - How are market leaders answering to the current sustainability challenges? Which sustainability goals did they set themselves? Which strategies have they put in place to achieve those goals? We will discuss these and other important questions in our free virtual Strybinar. Learn from successful industry leaders and innovators within the DACH market on ...
plusQCAM Currency Asset Management AG
With three new additions to the Board of Directors, QCAM Currency Asset Management AG underpins its leading position in Asset and Currency Management
plusVersameb raises CHF 6 million and strengthens team to advance its VERSagile technology platform towards clinical trials
Basel, Switzerland (ots) - Versameb AG, a biopharmaceutical company developing innovative ribonucleic acid (RNA) therapeutics, announced today the closing of a CHF 6 million seed financing round. Versameb further strengthens its team by the appointment of Dr. Klaas P. Zuideveld as Chief Development Officer effective ...
plus
Précédent12345678910Suivant